Simcere

Pharma

AZ, Boehringer-Simcere, Daiichi and more—Fierce Pharma Asia

AZ pledged a $15 billion China investment. BI and Simcere inked a potential $1 billion IBD deal. Daiichi is navigating a complex ADC market. And more.

Angus Liu Jan 30, 2026 7:45am

China biotech deals, Shionogi's ALS buy—Fierce Pharma Asia

Jan 9, 2026 3:00am

China approves 4 new drugs, including global 1st-in-class

Jul 2, 2025 11:32am

AstraZeneca-CSPC, FDA, NMPA—Fierce Pharma Asia

Jun 20, 2025 11:28am

AstraZeneca, BeiGene, Coherus—Fierce Pharma Asia

Dec 1, 2023 8:34am

Eisai-Biogen, Astellas-Pfizer, Novartis—Fierce Pharma Asia

Sep 30, 2022 9:15am